Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAMPs Summit 2025: reimagining possibilities in wound care.

Journal of wound care·2024
Same author

Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia.

Drug and alcohol review·2021
Same author

Implementation of NICE technology guidance on venous leg ulcers and diabetic foot ulcers: a conference report.

Journal of wound care·2019
Same author

Strategies for improving outcomes in venous leg ulcer care.

Journal of wound care·2018
Same author

Is there a difference between debridement and desloughing?

British journal of nursing (Mark Allen Publishing)·2015
Same author

The Academy of Physicians in Wound Healing (APWH).

Journal of wound care·2014
Same journal

Journal of wound care·2026
Same journal

Journal of wound care·2026
Same journal

Journal of wound care·2026
Same journal

Journal of wound care·2026
Same journal

Journal of wound care·2026
Same journal

Journal of wound care·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Making clinically informed R&D a reality.

Tracy Cowan

    Journal of Wound Care
    |January 14, 2012
    PubMed
    Summary
    This summary is machine-generated.

    The European Pressure Ulcer Advisory Panel (EPUAP) is hosting a focus meeting on technological innovations for pressure ulcer care. Clinicians can influence research and industry agendas in diagnosis, prevention, and treatment.

    More Related Videos

    Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
    11:28

    Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

    Published on: May 23, 2016

    Related Experiment Videos

    Last Updated: May 25, 2026

    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
    08:46

    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

    Published on: December 9, 2015

    Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
    11:28

    Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

    Published on: May 23, 2016

    Area of Science:

    • Wound Care and Technology
    • Clinical Innovation

    Background:

    • The European Pressure Ulcer Advisory Panel (EPUAP) is convening a focus meeting on technological advancements in pressure ulcer management.
    • The meeting addresses innovations in the diagnosis, prevention, and treatment of pressure ulcers.

    Discussion:

    • This event offers a platform for clinicians to engage with and shape the scientific direction of pressure ulcer research.
    • It highlights the importance of technological innovation amidst healthcare budget constraints.

    Key Insights:

    • Clinicians have an opportunity to influence the scientific agenda for pressure ulcer research and development.
    • Technological innovations are crucial for advancing pressure ulcer diagnosis, prevention, and treatment strategies.

    Outlook:

    • The meeting aims to foster collaboration between clinicians, researchers, and industry to drive progress in pressure ulcer care.
    • Future developments in pressure ulcer management will likely be influenced by this focus on technological integration.